NCT06925659View on ClinicalTrials.gov

A Study of QLM2011 in Subjects With Advanced Solid Tumors

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

172

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

February 28, 2027

Conditions

Advanced Solid Tumors

Interventions

DRUG

QLM2011

QLM2011l by intravenous infusion.

DRUG

Taxotere®

Taxotere® by intravenous infusion

All Listed Sponsors

lead

Qilu Pharmaceutical (Hainan) Co., Ltd.

INDUSTRY